8437439007
orders@99puritypeptides.com
CJC-1295 / Ipamorelin
Combination of CJC-1295 (long-acting GHRH analog) and Ipamorelin (GHSR agonist) to produce sustained baseline GH with superimposed pulses. Employed to dissect how different GH-release patterns affect body composition, recovery from training or injury, lipid metabolism, and general anabolic/catabolic balance.
For research use only – not for human or veterinary use, diagnosis, or treatment.
Price range: $67.50 through $1,000.00
Additional information
| Weight | 0.1 lbs |
|---|---|
| Strength | 10/10mg, 5/5mg |
| Volume | 3ML |
| Kit Sizes | Single, 5 Kit (Save 10%), 10 Kit (Best Value 🔥) |
CJC-1295 / Ipamorelin is a research peptide blend combining a growth hormone-releasing hormone (GHRH) analog (CJC-1295) with a selective growth hormone secretagogue receptor (GHSR-1a) agonist (Ipamorelin). In controlled laboratory settings, this dual-peptide formulation has been studied for its interaction with hypothalamic-pituitary axis signaling pathways and pulsatile growth hormone release mechanisms. Due to the complementary receptor activity of both compounds, the blend remains a focus in endocrine and metabolic research frameworks.
Preclinical investigations have examined CJC-1295 for its extended GHRH receptor activity and Ipamorelin for its selective ghrelin receptor pathway interaction. Scientific research continues to evaluate their combined receptor-binding dynamics, downstream IGF-1 signaling pathways, and intracellular endocrine modulation mechanisms within experimental models.
This research peptide blend is supplied in a 3ML vial and manufactured under strict laboratory-controlled standards. Each batch undergoes analytical verification to confirm molecular identity, purity, and structural integrity. CJC-1295 / Ipamorelin is intended strictly for laboratory research and analytical purposes only and is not for human consumption.
- GHRH analog and GHSR-1a agonist combination research
- Studied for hypothalamic-pituitary axis signaling models
- Investigated in pulsatile growth hormone release frameworks
- Evaluated for IGF-1 pathway interaction research
- Explored in endocrine peptide receptor dynamics studies
- Research-grade CJC-1295 / Ipamorelin peptide blend
- High-purity synthesis and formulation protocols
- Analytical verification (HPLC tested)
- Batch-specific quality control procedures
- Secure, laboratory-compliant packaging
Related products
-
Sale!
Sermorelin
Original price was: $105.00.$75.00Current price is: $75.00.A GHRH(1-29) analog representing the biologically active portion of native GHRH, used as a physiologic GH secretagogue.Add to cart -
Ipamorelin
Price range: $45.00 through $65.00A highly selective ghrelin receptor (GHSR-1a) agonist that stimulates GH release with minimal impact on other pituitary hormones.Select options This product has multiple variants. The options may be chosen on the product page -
Sale!
IGF-1 LR3 (IGF1-LR3)
Price range: $90.00 through $700.00A long-acting insulin-like growth factor-1 analog with reduced binding to IGF-binding proteins, leading to prolonged receptor activation.Select options This product has multiple variants. The options may be chosen on the product page -
Snap-8
$50.00A cosmetic octapeptide modeled on a fragment of SNAP-25 to influence SNARE complex–mediated neurotransmitter release at neuromuscular junctions.Add to cart
Questions
Common questions about research peptides, ordering, and lab standards
